508 material Form 8-K filings that 423 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Dime Community Bancshares agreed to sell 3,906,250 shares of common stock at $32.00 per share, for gross proceeds of $125 million. The company expects net proceeds of about $117.9 million, or about $135.7 million if underwriters exercise their option in full, and plans to use them for general corporate purposes, including investments in Dime Community Bank. Issuing these shares increases the number of shares outstanding, and the offering is expected to close on or about November 13, 2024.
3,906,250 shares sold at $32.00 per share, for gross proceeds of $125 million
Expected net proceeds of approximately $117.9 million; approximately $135.7 million if the underwriters' option is fully exercised
Underwriters hold a 30-day option to buy up to 585,937 additional shares
Offering expected to close on or about November 13, 2024; Raymond James & Associates and Keefe, Bruyette & Woods are representatives of the underwriters
PROG Holdings increased its Board from nine to eleven directors and appointed Robert Julian and Daniela Mielke to fill the new seats, effective November 12, 2024. Both were also named to the Audit Committee and were determined to be independent under NYSE and SEC rules. The filing describes routine board expansion with no financial results, compensation figures or related person transactions disclosed.
Board size increased from nine to eleven directors, effective November 12, 2024
Robert Julian and Daniela Mielke appointed as directors and as Audit Committee members
Both will receive standard non-employee director compensation and enter the company's standard indemnification agreement
Press release dated November 12, 2024 filed as Exhibit 99.1
Mosaic said its CFO, Clint Freeland, will retire in 2025 and resign as Executive Vice President and Chief Financial Officer on December 31, 2024. Luciano Siani Pires, a former Mosaic non-executive director, was appointed CFO-Designate effective November 18, 2024, and will become CFO on January 1, 2025, a planned leadership transition in the finance function.
Clint Freeland informed Mosaic on November 8, 2024, of his intention to retire; he resigns as CFO effective December 31, 2024, and remains a Senior Advisor until July 1, 2025.
Luciano Siani Pires starts November 18, 2024, as EVP and CFO-Designate and becomes EVP and CFO on January 1, 2025.
Base salary is $650,000 initially and rises to $800,000 on January 1, 2025; MIP target bonus is 75% of base, rising to 90%.
New-hire equity award valued at $1,000,000; March 2025 long-term incentive target is $2,500,000.
Elanco Animal Health appointed Dr. Stacey Ma, currently Executive Vice President of Pharmaceutical Development and Manufacturing at Gilead Sciences, to its Board of Directors effective immediately. The filing says the board was expanded from 14 to 15 members to accommodate the appointment. The change is governance-related and the filing reports no financial results or guidance.
Board appointment effective immediately; Dr. Ma named to Class III with a term expiring in 2027
Board size increased from 14 to 15 members
Dr. Ma also appointed to the Innovation, Science and Technology Committee
Announced in a press release dated November 12, 2024; board appointment made November 11, 2024
Community Financial System said its Executive Vice President and Chief Financial Officer, Joseph E. Sutaris, intends to retire in or around the third quarter of 2025, citing personal reasons. He will remain in his role until a successor is appointed and will stay through a transition period, and the company says the decision did not stem from any disagreement on financial statements or practices.
Joseph E. Sutaris notified the company on November 7, 2024 of his intention to retire.
Retirement is expected in or around the third quarter of 2025.
The company intends to begin a process to identify a successor; Sutaris will continue in his role until one is appointed.
The company states the retirement is for personal reasons and not due to any disagreement on financial statements, operations, policies, or practices.
RadNet reported third quarter 2024 revenue of $461.1 million, up 14.7%, and Adjusted EBITDA of $73.7 million, up 27.2%, with Adjusted diluted EPS of $0.18 versus $0.13. GAAP net income attributable to common stockholders fell to $3.2 million ($0.04 per diluted share) from $17.5 million ($0.25), and the company raised its Imaging Center revenue and Adjusted EBITDA guidance for 2024.
Q3 2024 Total Company Revenue was $461.1 million, up from $402.0 million; Adjusted EBITDA was $73.7 million, up from $57.9 million.
GAAP net income attributable to RadNet common stockholders was $3.2 million, or $0.04 per diluted share, versus $17.5 million, or $0.25, in Q3 2023; the company cited an $8.1 million non-cash loss from interest rate swaps among one-time ite
Adjusted diluted EPS was $0.18 versus $0.13 a year earlier.
Imaging Center 2024 guidance now projects Total Net Revenue of $1,710 - $1,760 million (up from $1,685 - $1,735 million) and Adjusted EBITDA of $262 - $270 million (up from $257 - $267 million).
Weyerhaeuser said senior vice president and chief development officer Russell Hagen will retire effective December 31, 2024, and will be succeeded by Paul Hossain, currently vice president of Natural Resources and Climate Solutions, effective January 1, 2025. Hossain will oversee the Real Estate, Energy & Natural Resources segment, including Natural Climate Solutions, along with business development and acquisitions and divestitures. Hagen will remain as a strategic advisor, but will no longer qualify for executive benefits, including executive severance and change of control.
Russell Hagen retires as senior vice president and chief development officer effective December 31, 2024; the board was notified on November 8, 2024.
Paul Hossain succeeds Hagen as senior vice president and chief development officer effective January 1, 2025.
Hossain will oversee the Real Estate, Energy & Natural Resources segment, Business Development, and Acquisitions and Divestitures.
Hagen stays on as a strategic advisor with no change to current compensation, but loses eligibility for executive severance and change-of-control benefits.
NCR Voyix approved performance-based restricted stock unit grants to five executives, effective November 8, 2024, including 208,478 units for CEO David Wilkinson. The awards cliff vest on November 8, 2027, and pay out only if the company's stock meets price hurdles starting at $22.00, with higher payouts at $24.00 and $26.00, so they tie executive pay to share price performance.
Grants effective November 8, 2024, approved by the Compensation and Human Resource Committee on November 6, 2024
CEO David Wilkinson receives 208,478 PBRSUs; Executive Chair James Kelly and CFO Brian Webb-Walsh each receive 104,239
Vesting is cliff-based on November 8, 2027, with a 20-day trailing average price of $22.00 required; payout is 125% at $24.00 and 150% at $26.00
CAVA Group reported fiscal third-quarter 2024 results for the period ended October 6, 2024, with CAVA segment revenue up 39.0% and net income rising to $18.0 million from $6.8 million a year earlier. The company also raised its fiscal 2024 guidance, lifting its Adjusted EBITDA forecast to $121.0 million to $126.0 million from $109.0 million to $114.0 million.
CAVA Revenue grew 39.0% to $241.5 million, versus $173.8 million in the prior-year quarter.
Net income was $18.0 million, or $0.15 per diluted share, compared with $6.8 million, or $0.06 per diluted share, a year earlier.
Fiscal 2024 guidance raised: CAVA Same Restaurant Sales Growth to 12.0% to 13.0% from 8.5% to 9.5%, and Adjusted EBITDA to $121.0 million to $126.0 million from $109.0 million to $114.0 million.
CAVA Restaurant-Level Profit Margin was 25.6%, compared with 25.1% in the prior-year quarter.
Fortinet's board increased its size from nine to ten directors and appointed Janet Napolitano, former Secretary of Homeland Security and former governor of Arizona, to fill the new seat, effective November 7, 2024. The filing describes the appointment as a governance change with no financial results attached, so it carries no direct effect on reported earnings or guidance.
Board expanded from nine to ten directors; Napolitano appointed effective November 7, 2024, to serve until the 2025 annual meeting.
Expected annual cash retainer of $55,000 for board service, plus any committee retainers; she has not yet been named to any committees.
Expected restricted stock unit grant, pro-rated to the 2025 annual meeting, vesting the day before that meeting.
ePlus reported fiscal second-quarter results for the three months ended September 30, 2024, with net sales down 12.3% and diluted earnings per share down to $1.17 from $1.22. Consolidated gross profit rose 2.5%, helped by services and financing revenue, and the company now expects fiscal 2025 net sales similar to fiscal 2024 and adjusted EBITDA of $195 million to $205 million.
Q2 net sales fell 12.3% to $515.2 million; product sales fell 22.2% to $389.6 million, while services revenue rose 46.0% to $103.7 million
Consolidated gross profit rose 2.5% to $148.0 million, and gross margin was 28.7%, compared with 24.6% a year earlier
Net earnings fell 4.1% to $31.3 million; adjusted EBITDA fell 2.7% to $52.1 million
Fiscal 2025 guidance: net sales now expected to be similar to fiscal 2024; adjusted EBITDA now expected at $195 million to $205 million
Rocket Lab reported third-quarter 2024 results on November 12, 2024. Revenue rose 55% year over year to $104.8 million, but the net loss widened to $51.9 million from $40.6 million, and the adjusted EBITDA loss grew to $30.9 million from $15.5 million. The company guided fourth-quarter revenue to $125 million to $135 million, which it describes as a record quarter.
Q3 2024 revenue was $104.8 million, up from $67.7 million in Q3 2023.
Net loss was $51.9 million, or $0.10 per share, compared with $40.6 million, or $0.08 per share, a year earlier.
Q4 2024 guidance calls for revenue of $125 million to $135 million and GAAP gross margins of 26% to 28%.
CEO Sir Peter Beck cited a backlog of $1.05 billion.
Phibro Animal Health disclosed that Rob Aukerman will retire as President, North America Region, effective December 31, 2024, and will stay on in an advisory role until June 30, 2025. Todd Armstrong, currently Vice President of the US Ruminant Business, will succeed him as President, North American Region, effective January 1, 2025. The filing describes a planned transition rather than a financial change.
Rob Aukerman notified the company on November 7, 2024 that he will retire effective December 31, 2024
Aukerman will continue in an advisory capacity until June 30, 2025
Todd Armstrong, Vice President of the US Ruminant Business since 2020, will be promoted to President, North American Region, effective January 1, 2025
Progyny reported third-quarter 2024 results on November 12, 2024. Revenue rose 2.0% to $286.6 million, but net income, gross margin and Adjusted EBITDA declined from a year earlier, and the company revised its full-year 2024 guidance lower. For shareholders, the revised outlook projects full-year 2024 revenue of $1.135 billion to $1.150 billion and net income of $49.9 million to $53.3 million, with the company citing unexpected variability in member treatment patterns.
Q3 2024 revenue rose 2.0% to $286.6 million, while net income fell to $10.4 million, or $0.11 per diluted share, from $15.9 million, or $0.16.
Gross margin fell to 20.7% from 22.3%, and Adjusted EBITDA was $46.5 million, down 7.1%.
Full-year 2024 revenue is now projected at $1.135 billion to $1.150 billion, and net income at $49.9 million to $53.3 million.
Fourth-quarter 2024 revenue is projected at $266.2 million to $281.2 million, or (1)% to 4% growth; a large client will not renew in 2025.
BioLife Solutions reported unaudited third-quarter 2024 revenue of $30.6 million, up 30% from a year earlier, and a GAAP net loss from continuing operations of $1.7 million, down from $15.8 million. The company also completed the $73.0 million cash sale of its SciSafe biostorage subsidiary on November 12, 2024, and cut its full-year 2024 total revenue guidance to $98.0 million to $100.0 million from $99.0 million to $101.0 million, citing the divestiture.
Q3 2024 total revenue was $30.6 million, up from $23.6 million in Q3 2023 and up 8% sequentially.
Q3 2024 GAAP net loss from continuing operations was $1.7 million, or $0.04 per share, versus $15.8 million, or $0.36 per share, a year earlier.
Adjusted EBITDA was $6.1 million, or 20% of revenue, compared with $1.4 million, or 6%, in Q3 2023.
Cell Processing 2024 revenue guidance was raised to $72.0 million to $73.0 million, while Biostorage Services guidance was lowered to $26.0 million to $27.0 million.
Dave Inc. reported third-quarter 2024 revenue of $92.5 million, up 41% from a year earlier, and net income of $0.5 million, compared with a net loss of $12.1 million in the same quarter of 2023. The company raised its full-year 2024 revenue guidance to $340 million to $343 million and its Adjusted EBITDA guidance to $71 million to $74 million, which is a positive signal for shareholders on both growth and profitability.
Q3 2024 revenue was $92.5 million, up 41% year over year, and net income was $0.5 million versus a $12.1 million loss in Q3 2023.
Q3 2024 Adjusted EBITDA was $24.7 million, compared with a $2.5 million loss in Q3 2023.
Full-year 2024 revenue guidance was raised to $340 million to $343 million from $310 million to $325 million.
Full-year 2024 Adjusted EBITDA guidance was raised to $71 million to $74 million from $40 million to $50 million.
ICU Medical reported third quarter 2024 revenue of $589.1 million, up from $553.3 million a year earlier, but swung to a GAAP net loss of $33.0 million from net income of $7.2 million. The company also widened its full-year 2024 GAAP net loss outlook, while narrowing its adjusted EBITDA range, so shareholders face a mixed picture on reported results and updated guidance.
Q3 2024 revenue was $589.1 million, up from $553.3 million in Q3 2023.
GAAP net loss was $33.0 million, or $1.35 per diluted share, versus net income of $7.2 million, or $0.30 per share, a year earlier.
Adjusted diluted EPS was $1.59 versus $1.57, and adjusted EBITDA was $94.8 million versus $89.8 million.
FY2024 GAAP net loss outlook moved to $122 million to $130 million from $108 million to $118 million; adjusted EBITDA outlook is now $355 million to $365 million.
NCR Atleos reported third quarter 2024 results on November 12, 2024. Revenue was $1.08 billion, up from $1.07 billion a year earlier, and GAAP net income attributable to Atleos was $24 million, compared with a net loss of $58 million a year earlier. The company reaffirmed its full-year 2024 guidance and said non-GAAP EPS guidance moved to the high end of its range, which matters to shareholders because it signals results ahead of the company's prior expectations.
Q3 revenue $1.08 billion vs. $1.07 billion a year earlier; Adjusted EBITDA $207 million vs. $210 million
GAAP diluted EPS $0.32 vs. loss of $0.82 a year earlier; non-GAAP diluted EPS $0.89
Full-year 2024 non-GAAP diluted EPS guidance of approximately $3.12, versus previous range of $2.90 to $3.20
October 17, 2024 debt refinancing reduced spread to SOFR by about 100 basis points on roughly $1.7 billion of variable rate debt
ZoomInfo reported third quarter 2024 results with GAAP revenue of $303.6 million, down 3% from a year earlier, and GAAP operating income of $43.5 million, down 31%. It raised its full-year 2024 adjusted net income per share guidance to $0.92-$0.93, from $0.86-$0.88 previously, while narrowing its full-year revenue guidance to $1.201-$1.204 billion.
Q3 2024 GAAP revenue was $303.6 million, down 3% year over year; GAAP diluted EPS was $0.07 versus $0.08 a year earlier.
Adjusted net income per share rose to $0.28 from $0.26, and adjusted operating income was $111.7 million, down 11%.
Full-year 2024 adjusted EPS guidance was raised to $0.92-$0.93; GAAP revenue guidance is $1.201-$1.204 billion, versus $1.190-$1.205 billion previously.
The company repurchased 24,478,696 shares for $242.1 million in the quarter, and has repurchased about 17% of outstanding shares since a buyback began in March 2023.
Life360 reported unaudited Q3 2024 total revenue of $92.9 million, up 18% year over year, and net income of $7.7 million, which the company said was helped by a one-time gain from investments and a tax benefit. It lowered its 2024 consolidated revenue guidance to $368 million-$374 million from $370 million-$378 million, citing lower hardware revenue, while raising its 2024 Adjusted EBITDA guidance to $39 million-$42 million from $36 million-$41 million.
Q3 2024 hardware revenue fell 24% year over year to $11.7 million, attributed to a delay in the new product launch.
2024 consolidated revenue guidance is $368 million-$374 million, down from $370 million-$378 million.
2024 Adjusted EBITDA guidance is $39 million-$42 million, up from $36 million-$41 million.
Q3 2024 net income was $7.7 million, including a $5.4 million gain on change in fair value of an investment; quarter-end cash was $160.2 million.
Maplebear Inc. (Instacart) reported third-quarter 2024 results on November 12, 2024, with GTV of $8,303 million, up 11% year-over-year, and total revenue of $852 million, up 12%. GAAP net income was $118 million and adjusted EBITDA was $227 million, up 39%, and the company gave a fourth-quarter GTV outlook of $8,500 million to $8,650 million. On November 5, 2024, the Board raised the share repurchase authorization to $750 million from $500 million, which matters to shareholders because it adds capacity to buy back stock.
Total revenue was $852 million, up 12% year-over-year; GAAP net income was $118 million, the fourth straight quarter of positive GAAP net income.
Adjusted EBITDA was $227 million, up 39%; operating cash flow was $185 million, up 67%.
Q4 2024 outlook: GTV of $8,500 million to $8,650 million and adjusted EBITDA of $230 million to $240 million.
Board approved a buyback of up to $750 million on November 5, 2024, up from $500 million authorized in June 2024; about $68 million remained under the previous program as of September 30, 2024.
Core Natural Resources, formerly CONSOL Energy, disclosed a separation agreement with General Counsel and Secretary Martha A. Wiegand, who departed on August 7, 2024. The agreement provides a lump sum of about $695,425, 18 months of COBRA premium payments, and accelerated vesting or continued eligibility for certain equity awards, which are costs the company is bearing for an executive exit.
Departure date: August 7, 2024; separation agreement signed November 6, 2024
Lump sum payment of approximately $695,425, conditional on a general release and a seven-day revocation period
Company to pay COBRA premiums for 18 months from the Separation Date
Equity awards that vest on employment alone are fully vested; performance awards remain eligible based on goal achievement
On November 12, 2024, Digital Realty Trust, L.P., a subsidiary of Digital Realty Trust, Inc., issued $1.15 billion of 1.875% exchangeable senior notes due November 15, 2029, including $150 million from the full exercise of the initial purchasers' option. The Company fully and unconditionally guaranteed the notes on a senior, unsecured basis, and the issuer may settle exchanges in cash or in a combination of cash and common shares. The filing adds a large debt obligation for the company, and shares could be issued if holders exchange their notes.
Principal of $1.15 billion, including $150 million from full exercise of the initial purchasers' option; interest of 1.875% per year payable May 15 and November 15, starting May 15, 2025
Initial exchange price of approximately $208.34 per share, equal to 4.7998 shares per $1,000 principal amount
Notes mature November 15, 2029; noteholders may exchange before August 15, 2029 only upon certain events
Company guarantee is senior and unsecured; a 3% maturity premium applies if a registration default event occurs
Perdoceo reported third-quarter 2024 revenue of $169.8 million, down 5.6% from the prior year quarter, and diluted EPS of $0.57 versus $0.62. The company raised its full-year 2024 outlook, with adjusted EPS now expected at $2.25 to $2.28, while revenue and reported EPS declined in the quarter.
Q3 2024 revenue $169.8 million, down 5.6%; year-to-date revenue $504.8 million, down 10.2%
Q3 diluted EPS $0.57 vs. $0.62; adjusted diluted EPS $0.59 vs. $0.64
Q3 operating income up 4.0% to $44.8 million; enrollments up 11.0% to 40,400
Full-year 2024 adjusted EPS outlook $2.25 to $2.28 vs. $2.10 in 2023; quarterly dividend of $0.13 per share payable December 13, 2024
Service Corporation International said that on November 6, 2024, its subsidiary OFTC, Inc. notified four executives that their employment agreements were extended to December 31, 2025. The filing is an administrative extension of existing agreements and does not disclose new pay terms, which are incorporated by reference from the March 27, 2024 proxy statement.
Executives covered: Thomas L. Ryan, Eric D. Tanzberger, Sumner J. Waring, III, and Elisabeth G. Nash
Notice dated November 6, 2024; agreements extended to December 31, 2025
Filing does not state changes to compensation; terms are referenced to the March 27, 2024 proxy statement
Filing signed November 12, 2024 by CFO Eric D. Tanzberger
Par Pacific Holdings announced that director Anthony Chase intends to resign from its Board of Directors and the Nominating and Corporate Governance Committee, effective November 15, 2024. The company says the resignation is for personal reasons and not due to any disagreement over its operations, policies, or practices.
Anthony Chase announced his resignation on November 7, 2024.
Resignation takes effect November 15, 2024, from the board and the Nominating and Corporate Governance Committee.
Company states the departure is for personal reasons, not a disagreement with management.
TE Connectivity said its Senior Vice President and Corporate Controller, Robert J. Ott, will retire effective January 3, 2025, and named Reuben M. Shaffer to succeed him. The filing also sets the 2025 Annual General Meeting for March 12, 2025, with shareholder notice and proposal deadlines in November 2024, which is routine governance information.
Robert J. Ott announced his intent to retire as Senior Vice President and Corporate Controller, effective January 3, 2025.
Reuben M. Shaffer, age 45, was appointed to succeed Ott upon his retirement; he has been Vice President, Assistant Corporate Controller since December 2023.
The 2025 Annual Meeting is scheduled for March 12, 2025; shareholders of record on January 9, 2025 may vote.
The deadline for shareholder proposals or director nominations for the 2025 meeting is November 22, 2024.
Clifton J. Porter II told Sabra's board on November 7, 2024, that he will not stand for reelection at the 2025 annual shareholder meeting. The filing says the decision does not involve any disagreement over the company's operations, policies or practices.
Notice given to the board on November 7, 2024
Porter will not stand for reelection at the 2025 annual meeting of shareholders
Filing states no disagreement with the company's operations, policies or practices
Porter is set to become President and CEO of AHCA/NCAL
CSX said its Executive Vice President and Chief Legal Officer, Nathan Goldman, will retire effective January 1, 2025, after a 21-year tenure. Michael Burns, a company veteran since 2006 who currently serves as vice president and general counsel, will be promoted to Senior Vice President and Chief Legal Officer effective January 2, 2025, as part of a planned succession process. The filing reports no financial figures, so the change is a leadership transition rather than a change in reported results.
Nathan D. Goldman, age 67, retires as EVP, Chief Legal Officer and Corporate Secretary effective January 1, 2025
Michael S. Burns, age 49, promoted to Senior Vice President, Chief Legal Officer and Corporate Secretary effective January 2, 2025
Burns previously served as Vice President, General Counsel and Assistant Corporate Secretary, and joined CSX in 2006
Burns will oversee legal and regulatory affairs, the corporate secretary's office, risk management, and audit functions, among others
BioLife Solutions completed the sale of its SciSafe subsidiary to Subzero Purchaser Corp. on November 12, 2024, for an aggregate price of $73.0 million, subject to adjustment. The same day, the company amended and restated its bylaws, including lowering the stockholder meeting quorum to one-third of voting power. The unaudited pro forma figures in the filing show a $39.6 million gain on the sale as of June 30, 2024, and SciSafe will be reported as discontinued operations from 2024 onward.
Sale of SciSafe to Subzero Purchaser Corp. closed November 12, 2024, for $73.0 million, subject to adjustment
BioLife paid former SciSafe stockholders about $3.3 million to waive certain earn-out payments and repaid about $0.9 million of SciSafe debt
Silicon Valley Bank loan amendment dated November 11, 2024 adds a $750,000 non-refundable termination fee
Amended bylaws, adopted November 12, 2024, set stockholder meeting quorum at one-third of voting power and add a Delaware exclusive forum provision
BJ's Wholesale Club Holdings said Jeff Desroches resigned as Executive Vice President, Chief Operations Officer on November 5, 2024. The company named Scott Schmadeke to succeed him as Executive Vice President, Chief Operations Officer, and Krystyna Kostka as Chief Supply Chain Officer. The change puts operations leadership under a long-serving internal executive, but the filing gives no financial figures or reasons for the departure.
Jeff Desroches resigned as Executive VP and Chief Operations Officer effective November 5, 2024
Scott Schmadeke, formerly SVP Field and Fresh Operations and a BJ's employee since 2018, named Executive VP and Chief Operations Officer, effective immediately
Krystyna Kostka, previously SVP Operations and with BJ's since 2014, named Chief Supply Chain Officer and will report to Schmadeke
AMN Healthcare's Chairman, Douglas D. Wheat, notified the company on November 9, 2024, that he will not stand for re-election at the 2025 annual meeting and will retire from the board then. The filing says his decision is not due to any disagreement with the company or board on operations, policies or practices. The board has named director Mark G. Foletta, on the board since 2012, as the next Chairman effective after that meeting, subject to his re-election.
Douglas D. Wheat notified the company on November 9, 2024, that he will not stand for re-election at the 2025 annual meeting.
Wheat's retirement is not tied to any disagreement with the company or board, according to the filing.
On November 11, 2024, the board appointed Mark G. Foletta, a director since 2012, as Chairman effective after the 2025 annual meeting, subject to his re-election.
Sunstone Hotel Investors reported third-quarter 2024 net income of $3.2 million, down from $15.6 million a year earlier, and lowered its full-year 2024 net income and Adjusted FFO per share guidance, citing labor activity at the Hilton San Diego Bayfront, Florida weather and a slower recovery in Maui. The company also entered a $100 million unsecured delayed draw term loan that it expects to draw in early December to repay a $72.1 million loan secured by the JW Marriott New Orleans, which it says would leave all its hotels unencumbered and no debt maturities before 2026.
Q3 2024 net income was $3.2 million versus $15.6 million in Q3 2023; Adjusted EBITDAre fell 15.9% to $53.6 million
Adjusted FFO per diluted share was $0.18 versus $0.23, down 21.7%; comparable RevPAR fell 1.3% to $207.56
Full-year 2024 net income guidance is now $31 million to $41 million, down from $43 million to $53 million; Adjusted FFO per share guidance is $0.75 to $0.80, down from $0.79 to $0.84
The $100 million term loan matures November 7, 2025, with two six-month extension options; the company repurchased 2,688,582 shares year to date through November 11, 2024
Repligen reported third-quarter 2024 revenue of $155 million, up 10% from a year earlier, and narrowed its full-year 2024 revenue guidance to $630 million-$639 million while keeping the midpoint unchanged. GAAP results swung to a small loss, which the company attributed in part to $17.4 million of incremental stock compensation tied to the CEO's transition to Executive Chair, and the filing references a prior restatement of financial statements.
Q3 2024 revenue $155 million vs. $141 million in Q3 2023, up 10%
GAAP net loss of $0.7 million, or $0.01 per diluted share, vs. net income of $17 million, or $0.30 per share
Adjusted (non-GAAP) diluted EPS $0.43 vs. $0.23; includes $17.4 million of CEO transition stock compensation excluded from adjusted results
Schrödinger reported third-quarter 2024 total revenue of $35.3 million, down from $42.6 million a year earlier, while software revenue rose 10%. The net loss narrowed to $38.1 million from $62.0 million, mainly due to changes in the fair value of equity investments, and the company raised the low end of its 2024 software revenue growth guidance. The company also said Novartis will pay $150 million upfront under a new collaboration.
Total revenue fell 17% to $35.3 million; software revenue rose 10% to $31.9 million, while drug discovery revenue fell to $3.4 million from $13.7 million.
Software gross margin decreased to 73% from 76%; operating expenses rose to $86.2 million from $79.8 million.
2024 software revenue growth guidance is now 8% to 13%; drug discovery revenue guidance is $20 million to $30 million.
Novartis will pay Schrödinger $150 million upfront under a multi-target collaboration announced November 12, 2024.
Roivant reported results for the quarter ended September 30, 2024, with a net loss attributable to the company of $230.2 million, or $0.31 per share, compared with $304.3 million, or $0.40 per share, a year earlier. Net revenue rose to $4.5 million from $3.6 million, but general and administrative expenses rose to $202.9 million, including $79.1 million of one-time cash retention awards, and the non-GAAP loss from continuing operations widened to $218.7 million from $154.8 million.
Net loss attributable to Roivant was $230.2 million ($0.31 per share) vs. $304.3 million ($0.40 per share) a year earlier.
Revenue, net was $4.5 million vs. $3.6 million; R&D expenses were $143.1 million vs. $114.8 million.
G&A expenses were $202.9 million vs. $88.6 million, including $79.1 million of one-time cash retention awards approved in July 2024.
Cash, cash equivalents and marketable securities were approximately $5.4 billion at September 30, 2024, after $106 million of share repurchases in the quarter.
Sylvamo reported third-quarter 2024 results that improved from the second quarter, with net sales of $965 million, net income of $95 million and diluted EPS of $2.27. The company also expects fourth-quarter 2024 adjusted EBITDA of $150 million to $165 million, below the $193 million reported for the third quarter, and says it will return at least 40% of free cash flow to shareowners this year.
Net sales $965 million vs. $933 million in Q2; net income $95 million ($2.27 per diluted share) vs. $83 million ($1.98).
Adjusted EBITDA $193 million (20% margin) vs. $164 million (18% margin) in Q2; free cash flow $119 million vs. $62 million.
Q4 2024 adjusted EBITDA outlook of $150 million to $165 million, including an $8 million operating expense for a planned turbine generator maintenance event at the Eastover, South Carolina, mill.
Q3 included a $7 million after-tax net special items charge ($0.17 per diluted share).
New Jersey Resources sold $100 million of 5.55% Senior Notes due November 7, 2034, to institutional investors on November 7, 2024. The notes are unsecured, guaranteed by certain unregulated subsidiaries, and proceeds are for general corporate purposes including possible acquisitions and debt repayment. The filing also reports the board committee's fiscal 2025 incentive and equity award structure for named executive officers, tied to net financial earnings and total shareholder return.
$100 million of 5.55% Senior Notes, Series 2024A, due November 7, 2034, sold in a private placement
Note Purchase Agreement limits consolidated total debt to 70% of total capitalization and priority debt to 20%
Fiscal 2025 Officer Annual Incentive Plan approved November 6, 2024; CEO target is 110% of base salary, other NEOs 40% to 60%
Performance share units vest over October 1, 2024 to September 30, 2027, payable from zero to 150% of granted units
Park Hotels & Resorts reinstated its full-year 2024 guidance on November 11, 2024, after labor agreements were ratified at four hotels in Hawaii, Seattle and Boston. The new outlook is lower than the July 31, 2024 outlook on every headline measure shown, including adjusted EBITDA, net income, diluted EPS and adjusted FFO per share. Shareholders face a lower earnings range for 2024, along with a fourth-quarter dividend expected to be $0.60 to $0.66 per share.
Adjusted EBITDA outlook is $635 million to $655 million, versus $660 million to $690 million on July 31, 2024.
Diluted EPS outlook is $0.68 to $0.77, versus $0.69 to $0.83 previously; adjusted FFO per share is $2.00 to $2.10, versus $2.10 to $2.26.
Preliminary October 2024 Comparable RevPAR fell 1.3% from October 2023; excluding the four affected hotels it rose 3.5%.
Mosaic reported third-quarter 2024 net income of $122 million, or $0.38 per diluted share, compared with a net loss of $4 million a year earlier, but revenue fell 21% to $2.8 billion on lower selling prices and adjusted EBITDA dropped to $448 million from $594 million. The company also said CFO Clint Freeland will retire, with Luciano Siani Pires succeeding him as chief financial officer on January 1, 2025.
Q3 2024 net income $122 million ($0.38 per diluted share) vs. net loss of $4 million in Q3 2023; adjusted EPS $0.34 vs. $0.68 a year earlier
Revenue $2.8 billion, down 21% from the year-ago period; adjusted EBITDA $448 million vs. $594 million
Clint Freeland to retire; Luciano Siani Pires joins as CFO designate November 18, 2024 and becomes CFO January 1, 2025
Year-to-date capital return of $415 million, including $210 million of share repurchases
Aramark reported fiscal 2024 revenue of $17.4 billion, up 8%, and operating income of $707 million, up 13%. GAAP earnings per share fell 42% to $0.99 because the prior year included a gain from the sale of its stake in AIM Services, while adjusted EPS rose 35% to $1.55. The board approved a $500 million share repurchase program and an 11% increase in the quarterly dividend, and guided fiscal 2025 adjusted operating income growth of 15% to 18%.
Fiscal 2024 revenue was $17.4 billion, up 8%, with organic revenue up 10%
Operating income rose 13% to $707 million; adjusted operating income rose 20% to $882 million
GAAP EPS was $0.99 versus $1.71 a year earlier; adjusted EPS was $1.55, up 35%
Fiscal 2025 outlook: organic revenue growth of 7.5% to 9.5%, adjusted operating income growth of 15% to 18%, and adjusted EPS growth of 23% to 28%
First Advantage reported third-quarter 2024 revenue of $199.1 million, down 0.6% from a year earlier, and a net loss of $8.9 million versus net income of $10.8 million in the prior-year quarter. The company closed its Sterling acquisition on October 31, 2024, and kept its standalone full-year 2024 guidance while issuing combined-company guidance that includes Sterling, which shareholders will need to weigh against the lower quarterly results.
Q3 2024 revenue was $199.1 million, versus $200.4 million in Q3 2023; adjusted EBITDA was $64.0 million, versus $64.8 million.
GAAP diluted net loss per share was $(0.06), versus diluted net income of $0.07 per share a year earlier; adjusted diluted EPS was $0.26, versus $0.28.
The net loss includes $13.2 million of expenses related to the Sterling acquisition.
Standalone 2024 revenue guidance of $750 million to $800 million was maintained; combined-company revenue guidance is $858 million to $918 million.
Zoetis announced on November 11, 2024 a set of executive changes. Jamie Brannan was named to a newly created Chief Commercial Officer role overseeing commercial operations in the U.S. and all international markets, and Keith Sarbaugh was promoted to Chief Digital & Technology Officer. Two executives are departing in early 2025, and the filing does not include any financial results or guidance.
Jamie Brannan appointed to newly created Executive Vice President and Chief Commercial Officer role, effective immediately, overseeing all commercial markets.
Wafaa Mamilli, Executive Vice President and Chief Digital & Technology Officer, will leave in early 2025 to pursue an external opportunity.
Ester Banque, Executive Vice President and President, U.S. Operations, will leave and serve in an advisory capacity until early 2025.
Jared Shriver promoted to President, U.S. Operations, reporting to Mr. Brannan, effective immediately.
Assured Guaranty reported third quarter 2024 GAAP net income of $171 million, or $3.17 per diluted share, up from $157 million, or $2.60, a year earlier. Adjusted operating income, the measure management uses for its core results, fell to $130 million, or $2.42 per share, from $206 million, or $3.42, partly because the 2023 period included a $241 million pre-tax gain from the Sound Point and AHP transactions.
GAAP net income was $171 million, or $3.17 per diluted share, for Q3 2024, versus $157 million, or $2.60, for Q3 2023; the company cited a $54 million foreign exchange gain among pre-tax adjustments.
Adjusted operating income was $130 million, or $2.42 per share, versus $206 million, or $3.42, in Q3 2023.
Q3 2024 capital returned to shareholders totaled $147 million, including $131 million of share repurchases and $16 million of dividends.
On November 8, 2024, the board authorized an additional $250 million of share repurchases; about $385 million remained authorized as of that date.
NW Natural Holdings reported a third-quarter 2024 net loss of $27.2 million ($0.71 per share), wider than the $23.7 million loss a year earlier, on operating revenues of $136.9 million, down 3%. Nine-month net income fell 31% to $33.9 million ($0.88 per share), which the company attributed mainly to regulatory lag, and it reaffirmed its 2024 GAAP EPS guidance of $1.94 to $2.14 while raising its dividend.
Q3 2024 net loss of $27.2 million ($0.71 per share) vs. a net loss of $23.7 million ($0.65 per share) in Q3 2023
Nine-month 2024 net income of $33.9 million ($0.88 per share) vs. $49.2 million ($1.37 per share) in 2023
2024 GAAP EPS guidance of $1.94 to $2.14 reaffirmed; non-GAAP Adjusted guidance of $2.20 to $2.40
Quarterly dividend of 49 cents per share, annual indicated rate $1.96, payable Nov. 15, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.